Department of Urology and Urological Oncology, Pomeranian Medical University, Szczecin, Poland.
Department of Anesthesiology, Intensive Therapy and Acute Intoxications, Pomeranian Medical University, Szczecin, Poland.
Clin Interv Aging. 2022 Mar 10;17:255-263. doi: 10.2147/CIA.S352890. eCollection 2022.
Muscle invasive bladder cancer (MIBC) is a common malignancy amongst elderly. Increasing life expectancy, prevalence of smoking, lifelong exposure to environmental pollutants and immunosenescence contribute to growing number of cases. Traditionally, radical cystectomy (RC) with pelvic lymph node dissection (PLND) constituted the mainstay of treatment for MIBC, but despite proven feasibility in elderly population, it has been associated with significant burden of morbidity, mortality, and complications.
We aimed to re-evaluate the safety and efficacy of RC amongst the elderly patients with MIBC.
This single-center, retrospective, observational comparative study was conducted among 568 patients who underwent RC due to MIBC between 2003 and 2021. We evaluated the influence of chronological age (<70 vs ≥70 years) on clinical, demographic, and pathological variables related to MIBC and RC.
Elderly patients had similar clinical and pathological features of disease compared to their younger counterparts; nonetheless, they more often received simplified urinary diversion, ie ureterostomy (60.25% vs 39.33%, p<0.001) and had no PLND (15.76% vs 8.5%, p=0.01) during RC. Furthermore, more elderly patients were treated for secondary MIBCs and fewer had history of smoking. Severe complication and 90-day mortality rates were comparable between groups; however, the elderly had significantly higher all-cause mortality at one year post RC (46.67% vs 33.25%, p=0.003). On multivariate analysis, one-year mortality risk was independently associated with elderly age (HR=2.119, 95% CI: 1.227-3.660, p=0.007), rural residency (HR=1.760, 95% CI: 1.043-2.968, p=0.034), extravesical extension of tumor (HR=2.109, 95% CI: 1.155-3.850, p=0.015), lymph node metastasis (HR=2.268, 95% CI: 1.290-3.987, p=0.004) and omission of PLND (HR=6.064, 95% CI: 2.926-12.568, p<0.001).
Radical cystectomy in elderly patients is associated with significant one-year mortality. Our study emphasizes the unmet need for considerate planning of treatment for MIBC in potentially vulnerable groups of elderly patients. Efforts are needed to reliably identify those unlikely to benefit from surgery and facilitate patient-centered choice of alternative therapies.
肌层浸润性膀胱癌(MIBC)是老年人中常见的恶性肿瘤。预期寿命的延长、吸烟的流行、终生接触环境污染物和免疫衰老导致病例数量不断增加。传统上,根治性膀胱切除术(RC)加盆腔淋巴结清扫术(PLND)是 MIBC 的主要治疗方法,但尽管在老年人群中已被证明具有可行性,但它与发病率、死亡率和并发症的显著负担有关。
我们旨在重新评估 MIBC 老年患者接受 RC 的安全性和疗效。
这是一项单中心、回顾性、观察性比较研究,共纳入 568 例 2003 年至 2021 年间因 MIBC 接受 RC 的患者。我们评估了年龄(<70 岁与≥70 岁)对 MIBC 和 RC 相关临床、人口统计学和病理变量的影响。
老年患者与年轻患者相比,具有相似的疾病临床和病理特征;然而,他们更常接受简化的尿流改道,即输尿管造口术(60.25% vs 39.33%,p<0.001),并且在 RC 期间不进行 PLND(15.76% vs 8.5%,p=0.01)。此外,更多的老年患者接受了二次 MIBC 治疗,而吸烟史较少。两组严重并发症和 90 天死亡率相当;然而,RC 后一年的全因死亡率,老年患者显著更高(46.67% vs 33.25%,p=0.003)。多变量分析显示,一年死亡风险与老年年龄独立相关(HR=2.119,95%CI:1.227-3.660,p=0.007),农村居住(HR=1.760,95%CI:1.043-2.968,p=0.034),肿瘤的膀胱外延伸(HR=2.109,95%CI:1.155-3.850,p=0.015),淋巴结转移(HR=2.268,95%CI:1.290-3.987,p=0.004)和 PLND 遗漏(HR=6.064,95%CI:2.926-12.568,p<0.001)。
老年患者接受 RC 与显著的一年死亡率相关。我们的研究强调了为 MIBC 高危老年患者制定治疗方案方面的未满足需求。需要努力可靠地识别那些不太可能从手术中获益的患者,并促进以患者为中心的替代治疗方案选择。